NEET Zoology · Biotechnology and its Applications
Biotechnology in Medicine
How human insulin is made in E. coli and why the C peptide matters, how gene therapy treats ADA deficiency, and which methods find a disease before its symptoms show.
Why this matters
Ten NEET questions: four on insulin, three on gene therapy for ADA deficiency and three on molecular diagnosis. The C peptide was asked in 2021 and 2022, and Eli Lilly's bacterium in 2025. The gene therapy questions are from 2021 and 2022 and the diagnosis questions from 2021 to 2023; ADA deficiency came back in two 2024 match questions.
Concept 1 of 3: Genetically engineered insulin
Definition
Insulin, as NCERT gives it:
- Adult-onset diabetes is managed by taking insulin at regular intervals.
- Insulin was earlier extracted from the pancreas of slaughtered cattle and pigs. Insulin from an animal source caused some patients to develop allergy or other reactions to the foreign protein.
- Insulin has two short polypeptide chains, A and B, linked by disulphide bridges.
- In mammals, including humans, insulin is made as a pro-hormone that contains an extra stretch called the C peptide. Like a pro-enzyme, the pro-hormone must be processed before it becomes a mature, functional hormone.
- The C peptide is not present in mature insulin: it is removed during maturation.
- The main challenge for making insulin by rDNA techniques was getting insulin assembled into a mature form.
- In 1983, Eli Lilly, an American company, prepared two DNA sequences for the A and B chains of human insulin and introduced them into the plasmids of E. coli. The chains were produced separately, extracted and combined by creating disulphide bonds to form human insulin.
- Insulin is a protein, so a dose swallowed by mouth would be digested in the gut like any other protein (NEET 2025 asked why it is not given orally).
- Recombinant therapeutics do not cause the unwanted immune responses common with similar products from non-human sources.
| Form of insulin | Has the C peptide? | Note |
|---|---|---|
| Pro-hormone (pro-insulin) | Yes | Must be processed into the mature hormone |
| Mature insulin | No | A and B chains joined by disulphide bridges |
| Insulin made by rDNA technology | No | A and B chains made separately in E. coli, then joinedQ NEET 2025: Eli Lilly used a bacterium (E. coli), not yeast, a virus or a phage. |
Practise this conceptself-check · 5 quick reps
The same idea in a real exam question:
Example 1 · Biotechnology and its Applications · Biotechnology in Medicine
Engineered insulin has no C peptide
Two chains, two genes
Read what the statement is about
Concept 2 of 3: Gene therapy for ADA deficiency
Definition
Gene therapy, as NCERT gives it:
- Gene therapy is a collection of methods that allows correction of a gene defect diagnosed in a child or embryo. Genes are inserted into a person's cells and tissues to treat a disease.
- Correction means delivering a normal gene into the person or embryo to take over the function of, and compensate for, the non-functional gene.
- The first clinical gene therapy was given in 1990 to a 4-year-old girl with adenosine deaminase (ADA) deficiency.
- The ADA enzyme is crucial for the immune system to work. The disorder is caused by deletion of the gene for adenosine deaminase.
- In some children it can be cured by bone marrow transplantation; in others it is treated by enzyme replacement therapy (functional ADA given by injection). Neither approach is completely curative.
- Gene therapy steps: lymphocytes from the patient's blood are grown in culture outside the body; a functional ADA cDNA is introduced into them using a retroviral vector; the cells are returned to the patient.
- These cells are not immortal, so the patient needs periodic infusion of genetically engineered lymphocytes.
- If the gene isolated from marrow cells producing ADA is introduced into cells at early embryonic stages, it could be a permanent cure.
| Treatment for ADA deficiency | What is done | Is it a lasting cure? |
|---|---|---|
| Bone marrow transplantation | New marrow given | Not completely curative |
| Enzyme replacement therapy | Functional ADA injected | Not completely curative |
| Gene therapy in lymphocytes | ADA cDNA put into cultured lymphocytes by a retroviral vector, then returned | No: the cells are not immortal, so infusions are repeated |
| Gene put into early embryonic cells | Gene from ADA-producing marrow cells introduced at early embryonic stages | Could be a permanent cure |
Practise this conceptself-check · 5 quick reps
The same idea in a real exam question:
Example 2 · Biotechnology and its Applications · Biotechnology in Medicine
The reason is short-lived cells
ADA deficiency is an immune disorder
Only the embryonic route is permanent
Concept 3 of 3: Molecular diagnosis
Definition
Molecular diagnosis, as NCERT gives it:
- Early diagnosis and understanding the pathophysiology of a disease are important for effective treatment.
- Conventional methods (serum and urine analysis) cannot detect a disease early.
- Recombinant DNA technology, PCR and ELISA serve the purpose of early diagnosis.
- A pathogen is usually suspected only after it has caused a symptom, when its concentration is already high.
- PCR amplifies the nucleic acid of a bacterium or virus, so a very low concentration can be found before symptoms show. PCR is routinely used to detect HIV in suspected AIDS patients, to find mutations in genes in suspected cancer patients, and to identify many other genetic disorders.
- Probe and autoradiography: a single-stranded DNA or RNA tagged with a radioactive molecule (the probe) is allowed to hybridise to its complementary DNA in a clone of cells, then detected by autoradiography. The clone with the mutated gene does not appear on the photographic film, because the probe has no complementarity with the mutated gene.
- ELISA is based on antigen-antibody interaction. It detects infection by the presence of antigens (proteins, glycoproteins) or of antibodies made against the pathogen.
| Method | What it detects | How |
|---|---|---|
| Serum and urine analysis | Disease, but late | Conventional method; no early detection |
| PCR | Very small amounts of a pathogen's nucleic acid; gene mutations | Amplifies the nucleic acid (used for HIV and suspected cancer) |
| Radioactive probe with autoradiography | A mutated gene | The mutated clone does not appear on the film, as the probe does not pair with itQ NEET 2021: the mutated gene does not appear on the film because the probe has no complementarity with it. |
| ELISA | Antigens of the pathogen, or antibodies against it | Antigen-antibody interaction |
Practise this conceptself-check · 5 quick reps
The same idea in a real exam question:
Example 3 · Biotechnology and its Applications · Biotechnology in Medicine
Serum and urine tests are not early tests
The mutated gene stays dark
ELISA is antibodies, PCR is nucleic acid
Summary — formulas & gotchas at a glance
A revision cheat-sheet for the formulas and gotchas above. Click any concept name to jump back to its full explanation.
Reference tables (3)
Genetically engineered insulin3 rows
| Form of insulin | Has the C peptide? | Note |
|---|---|---|
| Pro-hormone (pro-insulin) | Yes | Must be processed into the mature hormone |
| Mature insulin | No | A and B chains joined by disulphide bridges |
| Insulin made by rDNA technology | No | A and B chains made separately in E. coli, then joinedQ NEET 2025: Eli Lilly used a bacterium (E. coli), not yeast, a virus or a phage. |
Gene therapy for ADA deficiency4 rows
| Treatment for ADA deficiency | What is done | Is it a lasting cure? |
|---|---|---|
| Bone marrow transplantation | New marrow given | Not completely curative |
| Enzyme replacement therapy | Functional ADA injected | Not completely curative |
| Gene therapy in lymphocytes | ADA cDNA put into cultured lymphocytes by a retroviral vector, then returned | No: the cells are not immortal, so infusions are repeated |
| Gene put into early embryonic cells | Gene from ADA-producing marrow cells introduced at early embryonic stages | Could be a permanent cure |
Molecular diagnosis4 rows
| Method | What it detects | How |
|---|---|---|
| Serum and urine analysis | Disease, but late | Conventional method; no early detection |
| PCR | Very small amounts of a pathogen's nucleic acid; gene mutations | Amplifies the nucleic acid (used for HIV and suspected cancer) |
| Radioactive probe with autoradiography | A mutated gene | The mutated clone does not appear on the film, as the probe does not pair with itQ NEET 2021: the mutated gene does not appear on the film because the probe has no complementarity with it. |
| ELISA | Antigens of the pathogen, or antibodies against it | Antigen-antibody interaction |
Watch out for (9)
- Engineered insulin has no C peptide→ Genetically engineered insulin
- Two chains, two genes→ Genetically engineered insulin
- Read what the statement is about→ Genetically engineered insulin
- The reason is short-lived cells→ Gene therapy for ADA deficiency
- ADA deficiency is an immune disorder→ Gene therapy for ADA deficiency
- Only the embryonic route is permanent→ Gene therapy for ADA deficiency
- Serum and urine tests are not early tests→ Molecular diagnosis
- The mutated gene stays dark→ Molecular diagnosis
- ELISA is antibodies, PCR is nucleic acid→ Molecular diagnosis
Test yourself on a real paper
Sit a past NEET paper, timed and marked the way the exam marks it. You see your score and every answer the moment you finish. Free to start.